|
Real-time Estimate
Cboe BZX
09:44:36 11/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 514.92 USD | +0.07% |
|
-6.01% | +13.22% |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | 52.89x | 7.48x | 9.44x | 41.39x | 26.41x | 13TCr | ||
| 0.62% | 0.69% | 31.96x | 20.28x | 11.62x | 23.56x | 24.95x | 1,00100Cr | ||
| 2.02% | 2.11% | 29.63x | - | - | - | - | 64TCr | ||
| 2.69% | 2.83% | 32.65x | -357.19x | 7.56x | 15.72x | 16.34x | 45TCr | ||
| 2.9% | 2.97% | 18.78x | 6.87x | 4.58x | 11.35x | 12.58x | 34TCr | ||
| 3.19% | 3.33% | 19.52x | 5.55x | 5.11x | 12.66x | 13.5x | 26TCr | ||
| 2.1% | 2.24% | 20.44x | 4.57x | 4.2x | 12.01x | 12.63x | 25TCr | ||
| 2.64% | 2.79% | 24.19x | 18.27x | 6.38x | 11.35x | 14.63x | 21TCr | ||
| 3.94% | 3.93% | 12.74x | 5.41x | 4.63x | 9.67x | 11.27x | 20TCr | ||
| 2.27% | 2.31% | -43.8x | 10.78x | 6.4x | 24.98x | 60.44x | 18TCr | ||
| 6.23% | 6.28% | 17.44x | 1.8x | 3.3x | 8.44x | 9.6x | 16TCr | ||
| 3.96% | 4.03% | 11.36x | 5.35x | 3.19x | 8.27x | 8.97x | 13TCr | ||
| 5.78% | 6.11% | 11.72x | 1.19x | 2.09x | 6.76x | 7.48x | 10TCr | ||
| 3.92% | 4.22% | 13.55x | 4.34x | 2.71x | 8.02x | 8.92x | 9.62TCr | ||
| 2.12% | 2.42% | 20.86x | 4.7x | 6.95x | 13.19x | 13.85x | 6.86TCr | ||
| 3.61% | 3.68% | 44.79x | 1.21x | 2.75x | 9.73x | 27.52x | 5.86TCr | ||
| 0.33% | 1.15% | 22.02x | 1.7x | 1.7x | 8.02x | 13.79x | 5.56TCr | ||
| 0.57% | 0.65% | 30.83x | 4.16x | 7.14x | 24.17x | 27.03x | 4.21TCr | ||
| -.--% | -.--% | 52.05x | 4.91x | 3.27x | 12.07x | 13.65x | 4.24TCr | ||
| 2.4% | 2.66% | 17.51x | 1.75x | 3.21x | 11.96x | 13.33x | 4.01TCr | ||
| Average | 2.56% | 2.72% | 22.06x | -12.99x | 5.06x | 14.39x | 17.73x | 22.25TCr | |
| Weighted average by Cap. | 2.28% | 2.39% | 23.60x | -32.95x | 6.90x | 16.48x | 19.09x |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















